Log In
BCIQ
Print this Print this
 

Eligen Technology

  Manage Alerts
Collapse Summary General Information
Company Emisphere Technologies Inc.
DescriptionOral drug delivery platform that facilitates the absorption of small and large molecules via passive transcellular transport without altering chemical form, biological integrity or pharmacological properties
Molecular Target
Mechanism of Action 
Therapeutic ModalityMedical Devices: Drug/device combination
Latest Stage of DevelopmentPhase III
Standard IndicationDiabetes
Indication DetailsTreat type II diabetes
Regulatory Designation
PartnerNovo Nordisk A/S

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$62.5M

$10.0M

$120.0M


 Deals Details
Get a free BioCentury trial today